Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy

JM Martin, M Richardson, S Siva, M Cardoso… - The Lancet …, 2022 - thelancet.com
Urinary toxicity is common following pelvic radiotherapy and can have a substantial negative
effect on survivorship. Due to its prevalence and the increasing number of related clinical …

[HTML][HTML] Urological complications after radiation therapy—nothing ventured, nothing gained: a Narrative Review

J Chorbińska, W Krajewski… - Translational Cancer …, 2021 - ncbi.nlm.nih.gov
Radiation therapy along with chemotherapy and surgery are the three main treatment
modalities used in oncology. The main disadvantage of radiotherapy is the fact that it affects …

SABR for high-risk prostate cancer: A prospective multilevel MRI-based dose escalation trial

R Hannan, S Salamekh, NB Desai, A Garant… - International Journal of …, 2022 - Elsevier
Purpose Radiation dose intensification improves outcome in men with high-risk prostate
cancer (HR-PCa). A prospective trial was conducted to determine safety, feasibility, and …

[HTML][HTML] Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies

C Huck, V Achard, P Maitre, V Murthy, T Zilli - Clinical and Translational …, 2024 - Elsevier
In the past decade, stereotactic body radiation therapy (SBRT) has emerged as a valid
treatment option for patients with localized prostate cancer. Despite the promising results of …

Development of a management algorithm for acute and chronic radiation urethritis and cystitis

BGL Vanneste, EJ Van Limbergen… - Urologia …, 2022 - karger.com
Objective: The purpose of this review was to summarize the current literature on the
assessment and treatment of radiation urethritis and cystitis (RUC) for the development of an …

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome

I Strouthos, E Karagiannis, N Zamboglou… - Cancer …, 2022 - Wiley Online Library
Background High‐dose‐rate brachytherapy (HDR BRT) has been enjoying rapid
acceptance as a treatment modality offered to selected prostate cancer patients devoid of …

The management of patients diagnosed with incidental prostate cancer: narrative review

AR Abedi, S Ghiasy, M Fallah-Karkan… - … and Reports in …, 2020 - Taylor & Francis
14% of patients underwent surgery for benign prostate hyperplasia harboring prostate
cancer (PCa) focus. The best management of incidental prostate cancer (iPCa) has been …

Devastated bladder outlet in pelvic cancer survivors: issues on surgical reconstruction and quality of life

FE Martins, HV Holm, N Lumen - Journal of Clinical Medicine, 2021 - mdpi.com
Bladder outlet obstruction following treatment of pelvic cancer, predominantly prostate
cancer, occurs in 1–8% of patients. The high incidence of prostate cancer combined with the …

Surgical treatments of benign prostatic hyperplasia and prostate cancer stereotactic radiotherapy: impact on long-term genitourinary toxicity

C Huck, V Achard, T Zilli - Clinical Oncology, 2022 - Elsevier
Aims Although the results on acute and late toxicity of ultrahypofractionation are
encouraging, data on safety in prostate cancer patients with a medical history of …

[HTML][HTML] Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review

T Neerhut, R Grills, R Lynch, PD Preece… - … Oncology: Seminars and …, 2024 - Elsevier
Background When compared with conventional external beam radiotherapy,
hypofractionated radiotherapy has led to less treatment sessions and improved quality of life …